NASDAQ: FULC
Fulcrum Therapeutics Inc Stock Ownership - Who owns Fulcrum Therapeutics?

Insider buying vs selling

Have Fulcrum Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Kevin Tang10% Owner2026-07-1750,945$3.52
$179.33kBuy
Kevin Tang10% Owner2026-07-16116,671$3.56
$415.35kBuy
Kevin Tang10% Owner2026-07-15107,377$3.56
$382.26kBuy
Kevin Tang10% Owner2026-07-1475,952$3.58
$271.91kBuy
Kevin Tang10% Owner2026-07-1453,651$3.56
$191.00kBuy
Kevin Tang10% Owner2026-07-1312,966$3.54
$45.90kBuy
Alan EzekowitzDirector2026-06-2618,000$3.65
$65.61kSell
Robert J. GouldDirector2026-02-0215,000$10.72
$160.86kSell
Robert J. GouldDirector2026-01-0215,000$11.87
$178.10kSell
Robert J. GouldDirector2026-01-0215,000$10.87
$163.10kSell

1 of 2

FULC insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when FULC insiders and whales buy or sell their stock.

FULC Shareholders

What type of owners hold Fulcrum Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Kevin Tang17.99%13,744,328$51.54MInsider
Ra Capital Management LP17.09%13,053,960$48.95MInsider
Mark J. Levin7.92%6,046,425$22.67MInsider
Third Rock Ventures III LP3.27%2,499,343$9.37MInsider
Third Rock Ventures IV LP3.07%2,343,154$8.79MInsider
Glaxosmithkline PLC2.34%1,785,714$6.70MInsider
Casdin Capital LLC0.79%604,285$2.27MInsider
6 Dimensions Capital LP0.73%559,821$2.10MInsider
Sanofi0.73%558,035$2.09MInsider
Section 32 Fund 2 LP0.61%464,285$1.74MInsider

1 of 3

FULC vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
FULC0.10%55.84%Net Selling
EVMN0.08%51.09%Net BuyingNet Buying
AGMB0.06%0.32%Net BuyingNet Buying
KYTX0.06%41.95%Net Buying
AUTL0.05%0.54%Net BuyingNet Buying

Fulcrum Therapeutics Stock Ownership FAQ

Who owns Fulcrum Therapeutics?

Fulcrum Therapeutics (NASDAQ: FULC) is owned by 0.10% institutional shareholders, 55.84% Fulcrum Therapeutics insiders, and 44.06% retail investors. Kevin Tang is the largest individual Fulcrum Therapeutics shareholder, owning 13.74M shares representing 17.99% of the company. Kevin Tang's Fulcrum Therapeutics shares are currently valued at $51.13M.

If you're new to stock investing, here's how to buy Fulcrum Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.